Open AccessEffect of addition of either sitagliptin or pioglitazone in patients with uncontrolled type 2 diabetes mellitus on metformin: A randomized controlled trial
Author(s) -
Shalini Chawla,
Nitin Kaushik,
Narinder Pal Singh,
Raktim Ghosh,
Alpana Saxena
Publication year - 2013
Publication title -
journal of pharmacology and pharmacotherapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.301
H-Index - 34
eISSN - 0976-5018
pISSN - 0976-500X
DOI - 10.4103/0976-500x.107656
Subject(s) - sitagliptin , pioglitazone , metformin , medicine , hypoglycemia , body mass index , type 2 diabetes mellitus , diabetes mellitus , endocrinology , triglyceride , clinical endpoint , type 2 diabetes , gastroenterology , randomized controlled trial , pharmacology , cholesterol
To compare and study the dipeptidy1 peptidase-4 (DPP-4) inhibitors in combination with metformin against established combination therapies.